CholGate - The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners

This study has been completed.
Sponsor:
Collaborator:
Dutch Heart Foundation
Information provided by:
Erasmus Medical Center
ClinicalTrials.gov Identifier:
NCT00348751
First received: June 29, 2006
Last updated: May 7, 2008
Last verified: June 2006
  Purpose

Indirect evidence show alerting physicians with clinical decision support systems (CDSS) seem to change behaviour more than requiring users to actively initiate the system. However, randomized trials comparing these methods in a clinical setting are lacking. In this study we compare the effect of Alerting physicians with a CDSS or actively requiring initiation of CDSS on the adherence of Dutch general practitioners to the Cholesterol guideline of the Dutch college of General Practitioners.


Condition Intervention
Decision Support Systems, Clinical
Device: CholGate

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners - The CholGate Randomized Trial

Resource links provided by NLM:


Further study details as provided by Erasmus Medical Center:

Primary Outcome Measures:
  • The percentage of correctly screened patients using anonymous patient record data.
  • The percentage of correctly treated patients using anonymous patient record data.

Study Start Date: June 2004
Estimated Study Completion Date: November 2005
Detailed Description:

Indirect evidence show alerting physicians with clinical decision support systems (CDSS) seem to change behaviour more than requiring users to actively initiate the system. However, randomized trials comparing these methods in a clinical setting are lacking. In this study we compare the effect of Alerting physicians with a CDSS or actively requiring initiation of CDSS on the adherence of Dutch general practitioners to the Cholesterol guideline of the Dutch college of General Practitioners, using a clinical decsion support system called CholGate. This system has the functionality to provide both Alerting and On-Demand decision support. Users are free to negate the advise provided by the decision support system. The trial will have a cluster randomized structure.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • All general practices using only Elias electronic patient records (ISOFT b.V)
  • All patients meeting the screening and treatment criteria of the Dutch college of general practitioners cholesterol guideline

Exclusion Criteria:

  • Practices that used paper based records
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00348751

Locations
Netherlands
Department of Medical informatics, ErasmusMC
Rotterdam, South Holland, Netherlands, 3000DR
Sponsors and Collaborators
Erasmus Medical Center
Dutch Heart Foundation
Investigators
Principal Investigator: Jacobus T van Wyk, MD, PhD ErasmusMC University Medical Centre Rotterdam
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00348751     History of Changes
Other Study ID Numbers: 2000B161
Study First Received: June 29, 2006
Last Updated: May 7, 2008
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Additional relevant MeSH terms:
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases

ClinicalTrials.gov processed this record on July 24, 2014